1-5 of 5
Giuseppe Leone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Viral Load of Epstein–Barr Virus (EBV) DNA in Peripheral Blood Predicts for Biological and Clinical Characteristics in Hodgkin Lymphoma

Stefan Hohaus, Rosaria Santangelo, Manuela Giachelia, Barbara Vannata, Giuseppina Massini, Annarosa Cuccaro, Maurizio Martini, Valeriana Cesarini, Tonia Cenci, Francesco D'Alo, Maria Teresa Voso, Giovanni Fadda, Giuseppe Leone, Luigi M Larocca
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (9): 2885–2892.
https://doi.org/10.1158/1078-0432.CCR-10-3327
Published: 01 May 2011
View articletitled, The Viral Load of Epstein–Barr Virus (EBV) DNA in Peripheral Blood Predicts for Biological and Clinical Characteristics in Hodgkin Lymphoma
Open the PDF for The Viral Load of Epstein–Barr Virus (EBV) DNA in Peripheral Blood Predicts for Biological and Clinical Characteristics in Hodgkin Lymphoma in another window
Includes: Supplementary data
Journal Articles

Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic Syndromes

Maria Teresa Voso, Valeria Santini, Carlo Finelli, Pellegrino Musto, Enrico Pogliani, Emanuele Angelucci, Giuseppe Fioritoni, Giuliana Alimena, Luca Maurillo, Agostino Cortelezzi, Francesco Buccisano, Marco Gobbi, Lorenza Borin, Anna Di Tucci, Gina Zini, Maria Concetta Petti, Giovanni Martinelli, Emiliano Fabiani, Paola Fazi, Marco Vignetti, Alfonso Piciocchi, Vincenzo Liso, Sergio Amadori, Giuseppe Leone
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (15): 5002–5007.
https://doi.org/10.1158/1078-0432.CCR-09-0494
Published: 29 July 2009
View articletitled, Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic Syndromes
Open the PDF for Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic Syndromes in another window
Includes: Supplementary data
Journal Articles

Glutathione S-transferase P1 Genotype and Prognosis in Hodgkin's Lymphoma

Stefan Hohaus, Annalisa Di Ruscio, Annalaura Di Febo, Giuseppina Massini, Francesco D'Alo', Francesco Guidi, Giovanna Mansueto, Maria Teresa Voso, Giuseppe Leone
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (6): 2175–2179.
https://doi.org/10.1158/1078-0432.CCR-04-1250
Published: 23 March 2005
View articletitled, Glutathione S-transferase P1 Genotype and Prognosis in Hodgkin's Lymphoma
Open the PDF for Glutathione S-transferase P1 Genotype and Prognosis in Hodgkin's Lymphoma in another window
Journal Articles

Association between Glutathione S -Transferase Genotypes and Hodgkin’s Lymphoma Risk and Prognosis

Stefan Hohaus, Giuseppina Massini, Francesco D’Alo’, Francesco Guidi, Rossana Putzulu, Alessandra Scardocci, Andras Rabi, Anna Laura Di Febo, Maria Teresa Voso, Giuseppe Leone
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (9): 3435–3440.
Published: 05 September 2003
View articletitled, Association between Glutathione S -Transferase Genotypes and Hodgkin’s Lymphoma Risk and Prognosis
Open the PDF for Association between Glutathione S -Transferase Genotypes and Hodgkin’s Lymphoma Risk and Prognosis in another window
Journal Articles

Lymphocyte Recovery in Advanced Ovarian Cancer Patients after High-Dose Chemotherapy and Peripheral Blood Stem Cell Plus Growth Factor Support: Clinical Implications

Gabriella Ferrandina, Luca Pierelli, Alessandro Perillo, Sergio Rutella, Manuela Ludovisi, Giuseppe Leone, Salvatore Mancuso, Giovanni Scambia
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (1): 195–200.
Published: 01 January 2003
View articletitled, Lymphocyte Recovery in Advanced Ovarian Cancer Patients after High-Dose Chemotherapy and Peripheral Blood Stem Cell Plus Growth Factor Support: Clinical Implications
Open the PDF for Lymphocyte Recovery in Advanced Ovarian Cancer Patients after High-Dose Chemotherapy and Peripheral Blood Stem Cell Plus Growth Factor Support: Clinical Implications in another window